Coexistence of prostate cancer and disseminated hepatocellular carcinoma - a case report
Journal Title: Współczesna Onkologia - Year 2006, Vol 10, Issue 4
Abstract
A case of a 64-year old male with multiple bone metastases is presented. Because of elevated serum PSA level an oligobiopsy of the prostate was performed and a single focus of grade 1 prostatic cancer was found. The patient was treated with flutamide and gosereline. However, as the bone metastases progressed a surgical biopsy of the sternum was performed and a diagnosis of disseminated hepatocellular carcinoma was established. AFP serum level was normal. CT scan revealed a heterogeneous liver without focal lesions. A fine needle biopsy of the liver confirmed the diagnosis. The patient was treated ineffectively with palliative chemotherapy.
Authors and Affiliations
Katarzyna Szydłowska-Pazera, Piotr Potemski, Dorota Tomczyk, Robert Kubiak, Tomasz Jaworski, Anna Płużańska
Keywords
Related Articles
- EP ID EP118342
- DOI -
- Views 64
- Downloads 0
The prognostic value of cytokine levels in patients with cancer
We have demonstrated that the serum levels of many cytokines and soluble cytokine receptors are increased in a great proportion of patients with ovarian cancer, colorectal cancer, non-small cell lung carcinoma and soft t...
Effectiveness and toxicity of Interleukin 2, Interferon α, and 5-Fluorouracil in patients with Metastatic Renal Cell Cancer
Purpose: The purpose of this study was to evaluate the potential efficacy and toxicity for the treatment of metastatic renal cell cancer. Material and methods: During the first 4 weeks of treatment, patients rec...
Plasmid expression vector encoding sFLT-1 receptor (psFLT-1) inhibits angiogenesis and L1 tumour growth
Antiangiogenic gene therapy is based on genes encoding protein factors that suppress a process of new vessels formation – angiogenesis. It is common knowledge that angiogenesis is a crucial point of the tumour growth and...
Postępy w leczeniu przewlekłej białaczki limfocytowej B-komórkowej
Przewlekła białaczka limfocytowa B-komórkowa stanowi ok. 20–30% wszystkich białaczek u dorosłych. W 90% przypadków zachorowania dotyczą osób po 60. roku życia, a mężczyźni chorują 2-krotnie częściej niż kobiety. W osta...
High-dose chemotherapy supported with autologous hematopoietic stem cell transplant in small-cell lung cancer
Small-cell lung cancer provides clinicians with a paradox. Although it is a highly chemosensitive disease, it remains ultimately fatal for the majority of patients. The majority of patients respond to first-line chemothe...